Welcome to our dedicated page for Hippo Hldgs SEC filings (Ticker: HIPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hippo Holdings Inc. filings document formal disclosures for a NYSE-listed insurance technology company with common stock trading under HIPO. Recent Form 8-K reports furnish quarterly and annual operating results, investor presentations, supplemental financial information, and reconciliations of non-GAAP measures to GAAP measures.
The company’s proxy filings cover annual meeting materials, stockholder voting matters, board governance, and public-company disclosure requirements. Together, the filing record emphasizes Hippo’s insurance-platform performance, premium and underwriting metrics, capital and equity disclosures, and governance framework.
Michael Stienstra, General Manager & Chief Insurance Officer of Hippo Holdings Inc. (HIPO), reported a sale of 2,341 shares of Hippo common stock on 08/15/2025 at a price of $30.91 per share. After the transaction he beneficially owned 78,396 shares, which the filer notes includes 46,271 RSUs. The Form 4 was signed by an attorney-in-fact on 08/18/2025. The filing discloses the transaction code F indicating a sale, and provides the post-transaction beneficial ownership figure but no additional context about purpose of sale or planned transactions.
Torben Ostergaard, reporting person and officer at Hippo Holdings Inc. (HIPO), reported a sale of 2,016 shares of Hippo common stock on 08/15/2025 at a price of $30.91 per share. After the transaction he beneficially owned 62,333 shares, which the filing notes include 56,121 RSUs. The Form 4 was signed by an attorney-in-fact on 08/18/2025. The filing provides only the single non-derivative sale and the post-transaction beneficial ownership amount.
Hippo Holdings Inc. insider transaction: Chief Financial Officer and director Guy Zeltser reported a sale of 3,973 shares of Hippo common stock on 08/15/2025 at a price of $30.91 per share. After the transaction he beneficially owned 81,067 shares, which the filing states includes 67,842 RSUs. The Form 4 is signed by Guy Zeltser on 08/18/2025. The filing identifies his role as Chief Financial Officer and Director and is reported under Section 16.
Richard McCathron, Chief Executive Officer and Director of Hippo Holdings Inc. (HIPO), reported an open-market sale of 10,759 shares of Hippo common stock on 08/15/2025 at a price of $30.91 per share. After the reported disposition, McCathron beneficially owned 475,388 shares, which the filing notes includes 212,464 RSUs. The Form 4 was signed by an attorney-in-fact on 08/18/2025. The filing discloses the transaction and the remaining stake but does not provide context such as whether the sale was pursuant to a pre-arranged trading plan or for personal reasons.